Search for:

Temasek, through its Asia Sustainable Foods Platform, and Cremer jointly invest S$6 million in production facility to grow alternative protein sector.

In brief

Singapore state investor Temasek, through its Asia Sustainable Foods Platform (ASF), and Cremer, a German agri-food multinational company, have jointly invested SGD 6 million to produce plant-based alternative proteins in Tuas, Singapore.

ASF and Cremer have formed the joint venture, Cremer Sustainable Foods, which will carry out pilots and demo-scale facilities for the joint venture’s first Singapore production facility.


  2. In more detail
  3. Key considerations


This project is in alignment with Singapore’s aim to position itself as an agri-foodtech hub in Asia and globally. Through the contract development and manufacturing operation facility, food tech companies will not need to establish their own facilities and can scale up in an asset-light manner.

In scaling up, food tech companies should be mindful of the Singapore Food Agency’s (SFA) regulatory requirements especially in the novel food space.

In more detail

Temasek, through ASF, and Cremer have jointly invested S$6 million in a production facility, to grow its capabilities in the alternative protein sector. ASF and Cremer have formed Cremer Sustainable Foods as a joint venture, which will carry out pilots and demo-scale facilities using its high moisture extrusion technology.

This will strengthen Singapore’s manufacturing capabilities and support businesses in the alternative protein sector.

The facility’s operations will commence from 1 August 2022 for the manufacture of 1,000 tonnes of alternative protein product for a client. Cremer Sustainable Foods is currently also in discussions with 4 to 5 other potential clients.

The contract development and manufacturing operation facility is expected to produce up to 1,300 tonnes of high-consistency, plant-based products that closely mimic conventional meat per year.

Through this facility, food tech companies will no longer have to establish their own facilities. Instead, they can scale up business in an asset-light manner.

Key considerations

Food tech companies dealing in novel food products must be mindful of applicable regulatory requirements for novel food products in Singapore. Some key issues in relation to regulatory requirements relating to novel foods include:

  • Obtaining pre-market regulatory approval from the SFA;
  • Adhering to the safety assessment criteria set out in the SFA’s guidelines for the safety assessment of novel food and novel food ingredients;
  • Obtaining licences and/or registrations before the import / export / manufacture / supplying of such novel food products;
  • Adhering to applicable legislation (e.g., Sale of Food Act 1973 and the Food Regulations); and
  • Complying with packaging and labelling requirements.

It is imperative for food tech companies to prioritise safety through using safe methods and safe ingredients. The SFA’s safety assessment guidelines are a good starting position for companies to consider whether their novel food products are safe for the import into and sale in Singapore.


© 2022 Baker & McKenzie.Wong & Leow. All rights reserved. Baker & McKenzie.Wong & Leow is incorporated with limited liability and is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a “principal” means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an “office” means an office of any such law firm. This may qualify as “Attorney Advertising” requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.


Andy Leck is the head of the Intellectual Property and Technology (IPTech) Practice Group and a member of the Dispute Resolution Practice Group in Singapore. He is a core member of Baker McKenzie's regional IP practice and also leads the Myanmar IP Practice Group. Andy is recognised by reputable global industry and legal publications as a leader in his field. He was named on "The A-List: Singapore's Top 100 lawyers" by Asia Business Law Journal 2018. In addition, Chambers Asia Pacific notes that Andy is "a well-known IP practitioner who is highlighted for his record of handling major trade mark litigation, as well as commercial exploitation of IP rights in the media and technology sectors. He's been in the industry for a long time and has always been held in high regard. He is known to be very fair and is someone you would like to be in the trenches with you during negotiations." Furthermore, Asian Legal Business acknowledges Andy as a leading practitioner in his field and notes that he “always gives good, quick advice, [is] client-focused and has strong technical knowledge for his areas of practice.” Andy was appointed by the Intellectual Property Office of Singapore (IPOS) as an IP Adjudicator to hear disputes at IPOS for a two-year term from April 2021. He has been an appointed member of the Singapore Copyright Tribunal since May 2010 and a mediator with the WIPO Arbitration and Mediation Center. He is also appointed as a Notary Public & Commissioner for Oaths in Singapore. He previously served on the International Trademark Association’s Board of Directors and was a member of the executive committee.


Ren Jun Lim is a principal with Baker McKenzie Wong & Leow. He represents local and international clients in both contentious and non-contentious intellectual property matters. He also advises on a full range of healthcare, as well as consumer goods-related legal and regulatory issues. Ren Jun co-leads Baker McKenzie Wong & Leow's Healthcare as well as Consumer Goods & Retail industry groups. He sits on the Law Society of Singapore IP Committee and on the Executive Committee of the Association of Information Security Professionals. He is also a member of the Vaccines Working Group, Singapore Association of Pharmaceutical Industries, a member of the International Trademark Association, as well as a member of the Regulatory Affairs Professionals Association. Ren Jun is ranked in the Silver tier for Individuals: Enforcement and Litigation and Individuals: Prosecution and Strategy, and a recommended lawyer for Individuals: Transactions by WTR 1000, 2020. He is also listed in Asia IP's Best 50 IP Expert, 2020, recognised as a Rising Star by Managing IP: IP Stars, 2019 and one of Singapore's 70 most influential lawyers aged 40 and under by Singapore Business Review, 2016. Ren Jun was acknowledged by WTR 1000 as a "trademark connoisseur who boasts supplementary knowledge of regulatory issues in the consumer products industry." He was also commended by clients for being "very responsive to enquiries and with a keen eye for detail, he is extremely hands-on. His meticulous and in-depth approach to strategising is key to the excellent outcomes we enjoy."

Write A Comment